Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_assertion type Assertion NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_head.
- NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_provenance.
- NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_assertion evidence source_evidence_literature NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_provenance.
- NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_assertion SIO_000772 2356863 NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_provenance.
- NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_assertion wasDerivedFrom befree-20140225 NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_provenance.
- NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_assertion wasGeneratedBy ECO_0000203 NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_provenance.